{
    "$schema": "http://json-schema.org/draft-07/schema#",
    "$id": "karatestorg20201105-neuro.treatmentType-0.0.1",
    "description": "",
    "anyOf": [
        {
            "const": "haloperidol",
            "description": "A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety",
            "source": "http://purl.obolibrary.org/obo/CHEBI_5613"
        },
        {
            "const": "levetiracetam",
            "description": "A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine.",
            "source": "http://purl.obolibrary.org/obo/CHEBI_6437"
        },
        {
            "const": "placebo",
            "description": "A negative reference substance is a reference role in which the substance playing the reference substance role is physically similar in appearance to the test substance",
            "source": "http://purl.obolibrary.org/obo/OBI_0000169"
        },
        {
            "const": "clozapine",
            "description": "A second generation antipsychotic used in the treatment of psychiatric disorders like schizophrenia.",
            "source": "http://purl.obolibrary.org/obo/CHEBI_3766"
        }
    ]
}

